GlassScriptPhysician profile
Kandi Campbell
NPI 1922738129
$644.93
in general payments reported to CMS, 2019-2025
16 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $88.51 · 2023: $34.27 · 2024: $188 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $182.69 | 2024-2025 | Farxiga |
| Novo Nordisk INC | $79.57 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Sanofi-Aventis U.S. LLC | $49.92 | 2025 | |
| Sanofi Pasteur INC. | $44.30 | 2025 | |
| Amgen INC. | $40.99 | 2022-2025 | Otezla, Repatha |
| Medline Industries LP | $35.31 | 2022 | |
| Abbvie INC. | $28.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $27.45 | 2025 | |
| Ironshore Pharmaceuticals INC. | $22.86 | 2022 | |
| Alexion Pharmaceuticals, INC. | $21.35 | 2024 | Strensiq |
| Ucb, INC. | $21.03 | 2025 | Bimzelx |
| Merck Sharp & Dohme LLC | $20.44 | 2023 | Dificid, Delstrigo, Pifeltro |
| E.R. Squibb & Sons, L.L.C. | $20.01 | 2025 | Camzyos |
| Exact Sciences Corporation | $19.89 | 2025 | The Cologuard Plus Collection Kit |
| Smith+Nephew, INC. | $17.29 | 2025 | Collagenase Santyl |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $13.83 | 2023 | Prevena, V.A.C.Instill |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kandi Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.